Live stream preview
Low-dose Naltrexone: What's New
57m
Join us to discover the latest and greatest in naltrexone compounding with PCCA Clinical Compounding Pharmacist Sebastian Denison, RPh. He'll share updated information you need to know, plus uncover new compounding options to grow your practice.
You'll learn:
New and updated LDN dosing considerations
How LDN is changing the world of dermatology
LDN benefits for cancer patients — and how it can be the starting point for your entry into the oncology practice setting